Serotonin-2B receptor antagonism increases the activity of dopamine and glutamate neurons in the presence of selective serotonin reuptake inhibition

Positive regulation of raphe serotonin neurons by serotonin 2B receptors

(2018) Arnauld Belmer et al.   NEUROPSYCHOPHARMACOLOGY

The central serotonin 2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research

(2018) Céline Devroye et al.   PHARMACOLOGY & THERAPEUTICS

Serotonin2B receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons

(2018) Adeline Cathala et al.   EXPERIMENTAL NEUROLOGY

Synergistic effect of aripiprazole and escitalopram in increasing serotonin but not norepinephrine neurotransmission in the rat hippocampus

(2018) Mohammad Ebrahimzadeh et al.   NEUROPHARMACOLOGY

Serotonin 2B Receptors in Mesoaccumbens Dopamine Pathway Regulate Cocaine Responses

(2017) Stéphane Doly et al.   JOURNAL OF NEUROSCIENCE

Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin 2B receptor blockade: Involvement of medial prefrontal cortex serotonin 1A receptors

(2017) Céline Devroye et al.   NEUROPHARMACOLOGY

Subchronic vortioxetine treatment –but not escitalopram– enhances pyramidal neuron activity in the rat prefrontal cortex

(2017) Maurizio S. Riga et al.   NEUROPHARMACOLOGY

Mice lacking the serotonin 5-HT 2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants

(2016) Silvina Laura Diaz et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Differential control of dopamine ascending pathways by serotonin 2B receptor antagonists: New opportunities for the treatment of schizophrenia

(2016) Céline Devroye et al.   NEUROPHARMACOLOGY

Pharmacological Evidence for 5-HT6 Receptor Modulation of 5-HT Neuron Firing in Vivo

(2015) Julia T. Brouard et al.   ACS Chemical Neuroscience

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

(2015) Joseph Zohar et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons

(2013) Franck Chenu et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons

(2012) Mark A. Ungless et al.   TRENDS IN NEUROSCIENCES

5-HT2B receptors are required for serotonin-selective antidepressant actions

(2011) S L Diaz et al.   MOLECULAR PSYCHIATRY

Implication of 5-HT2B receptors in the serotonin syndrome

(2011) Silvina Laura Diaz et al.   NEUROPHARMACOLOGY

Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission

(2011) Shunsuke Tanahashi et al.   NEUROPHARMACOLOGY

Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy

(2011) Ouissame Mnie-Filali et al.   NEUROPSYCHOPHARMACOLOGY

Expression and Function of Serotonin 2A and 2B Receptors in the Mammalian Respiratory Network

(2011) Marcus Niebert et al.   PLoS One

Deconstructing Antiobesity Compound Action: Requirement of Serotonin 5-HT2B Receptors for Dexfenfluramine Anorectic Effects

(2010) Sophie M Banas et al.   NEUROPSYCHOPHARMACOLOGY

Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder

(2009) Olga Chernoloz et al.   PSYCHOPHARMACOLOGY

Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex

(2008) N. Santana et al.   CEREBRAL CORTEX

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

(2008) M. Shahid et al.   JOURNAL OF PSYCHOPHARMACOLOGY